About Conference

Last Round of abstract submission: March 12, 2018 | Welcome Message


Science Access is pleased to welcomes you all for “World cancer conference 2018” which is going to be held from March 19th to 21st at Valencia, Spain. The theme of the congress is Research Today For a Cancer Free Tomorrow.
Cancer 2018 will provide an unparalleled prospect to get associated with leading oncologists, doctors, scientists, academicians, specialists & business associates coming from all over the world. As the theme of the conference relates it serves as a global platform to converse concerning the current developments, recent advances, new approaches and future approaches in the field of cancer science & therapy.
World Cancer Conference 2018   unites the leading experts over the world to explore their research on cancer. Advancements of techniques to Cancer Immunology, Cancer Vaccines, Cancer drugs and health issues are under constant growth over the last decade as person’s healthy smile depends on an oral health. This World congress will provide a distinctive forum to meet eminent personalities and experience inspiring talks in the field of Cancer and there will be a great affiliation of scientists, professors and industrialists during exciting round table discussions, question answer sessions and unique poster presentations which will help in modernization and advancement of Cancer. Book mark your days from March 19th to 21st for 3 days “World cancer conference” at Valencia, Spain.
Cancer Market Statistics
The global oncology drug market is expected to reach $ 150 billion by 2020 from $ 107 billion in 2015 – registering annual growth rate of 7.5-10.5 present through 2020, according to a new study released by the IMS Institute for Healthcare Informatics.
More than 20 tumour types are being treated with one or more of the 70 new cancer treatments that have been launched in the past five years, with the sustained surge in innovative therapies driving the global oncology market, added the study – titled ‘Global Oncology trend report: A review of 2015 and outlook to 2020’. However, as per the study, many of these drugs are not yet available to patients in most countries, and even when registered they may not be reimbursed under public insurance programs.
Annual global growth in the oncology drug market is expected to be 7.5 – 10.5 present through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes. Global cancer drugs market is primarily driven by growing incidences of target disease such as lung cancer, breast cancer, cervical cancer, etc. across the globe. 
It is expected to reach $111.9 billion by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes. 
Reuters reported that “this increase in spending represents an annual global growth rate for oncology drug spending of 7.5% to 10.5% through 2020, up from last year’s IMS forecast of 6% to 8% growth through 2018”.





Authorization Policy: By registering for the conference you grant permission to SCIENCEACCESS to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or video recording by participants/others during conference is prohibited without prior approval. Contact us for any queries. Privacy is Everyone's Concern!